Key facts
- Notable investors include Claret Capital Partners, Intrinsic Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ACT LAB
- ·The full record, as it builds
Funding rounds
No funding rounds for ACT LAB are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ACT LAB
Provider of laboratory testing services intended for cultivators, processors, and dispensaries to satisfy state requirements for a broad spectrum of tests. The company operates in the cannabis space and offers full-scope compliance and testing services, enabling clients to ensure product safety for patients and consumers.
- Sector
- Healthcare
- HQ
- Lansing, MI, United States
- Founded
- 2010
- Employees
- 96
- Website
- actlab.com/
- Ownership
- Privately Held (backing)
ACT LAB doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ACT LAB shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ACT LAB in its N-PORT filings yet. We sweep new filings monthly.